Aura Biosciences Stock (NASDAQ:AURA), Quotes and News Summary

Q: What sector and industry does Aura Biosciences (AURA) operate in?

Aura Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Aura Biosciences Stock (NASDAQ: AURA) stock price, news, charts, stock research, profile.

Open	$7.320
Close	$7.530
Volume / Avg.	144.400K / 177.756K
Day Range	7.180 - 7.680
52 Wk Range	5.990 - 13.500
Market Cap	$373.061M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	57
Short Interest	7.08%
Days to Cover	23.02

Recent News

Over $13M Bet On This Energy Stock? Check Out These 4 Stocks Insiders Are Buying

Although U.S. stocks closed lower on Thursday, there were a few notable insider trades.

Lisa Levin

Why Aura Biosciences Stock Hit A New 52-Week Low Today

Aura Biosciences Inc (NASDAQ: AURA) shares are trading lower by 34.7% to $7.18 Tuesday afternoon after the company announced pricing of its public offering of common st

Henry Khederian

Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spectrum disorder Phase 2 study results in the Annals of General Psychiatry.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Dec 23

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Aura Biosciences Inc

Sector

Health Care

Industry

Biotechnology

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Aura Biosciences (AURA) stock?

You can purchase shares of Aura Biosciences (NASDAQ: AURA) through any online brokerage.

View our list of the best stock brokerages.

Who are Aura Biosciences's (AURA) competitors?

Other companies in Aura Biosciences’s space includes: Precigen (NASDAQ:PGEN), Replimune Group (NASDAQ:REPL), Anika Therapeutics (NASDAQ:ANIK), TScan Therapeutics (NASDAQ:TCRX) and Neurogene (NASDAQ:NGNE).

What is the target price for Aura Biosciences (AURA) stock?

The latest price target for Aura Biosciences (NASDAQ: AURA) was reported by BTIG on Friday, December 8, 2023. The analyst firm set a price target for 21.00 expecting AURA to rise to within 12 months (a possible 178.88% upside). 3 analyst firms have reported ratings in the last year.

Current Stock Price for Aura Biosciences (AURA)?

The stock price for Aura Biosciences (NASDAQ: AURA) is $7.53 last updated May 14, 2024 at 4:00 PM EDT.

Does Aura Biosciences (AURA) pay a dividend?

There are no upcoming dividends for Aura Biosciences.

When is Aura Biosciences (NASDAQ:AURA) reporting earnings?

Aura Biosciences’s Q2 earnings are confirmed for Wednesday, August 7, 2024.

Is Aura Biosciences (AURA) going to split?

There is no upcoming split for Aura Biosciences.

What sector and industry does Aura Biosciences (AURA) operate in?

Aura Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-